All sites C00-96,D32-33,D42-43,D45-47,D76 449 88.6 2.1 4.4 1.2 3.7
Mouth, pharynx C00-14 5 100.0 - - - -
  Lip C00 1 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 97 77.9 0.8 11.4 2.5 7.4
  Oesophagus C15 2 100.0 - - - -
  Stomach C16 11 92.6 - 1.9 - 5.6
  Small intestine C17 2 100.0 - - - -
  Colon C18 31 89.7 0.6 5.1 1.9 2.6
  Rectum, rectosigmoid C19-20 15 98.7 - - 1.3 -
  Anus C21 1 100.0 - - - -
  Liver C22 6 64.3 3.6 25.0 - 7.1
  Gallbladder, bile ducts C23-24 5 52.2 4.3 8.7 8.7 26.1
  Pancreas C25 21 45.8 0.9 30.8 3.7 18.7
  Other digestive organs C26 3 53.3 - 26.7 13.3 6.7
Respiratory organs C30-39 25 63.2 12.0 11.2 1.6 12.0
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 23 64.1 12.0 11.1 1.7 11.1
  Mediastinum, pleura C38 0 - - 50.0 - 50.0
Bone C40-41 - - - - - -
Melanoma of the skin C43 15 100.0 - - - -
Skin, non-melanoma C44 22 99.1 - - 0.9 -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 134 99.1 0.3 - 0.1 0.4
Female genital organs C51-58 61 93.8 2.0 1.0 1.6 1.6
  Cervix uteri C53 8 100.0 - - - -
  Corpus uteri C54 29 96.5 - - 1.4 2.1
  Uterus, other C55,C58 1 50.0 - - 25.0 25.0
  Ovary C56 19 89.2 4.3 3.2 2.2 1.1
  Other female genital C51-52,C57 5 92.3 7.7 - - -
Urinary organs C64-68 18 91.2 - 5.5 - 3.3
  Kidney C64 11 90.6 - 5.7 - 3.8
  Bladder and urinary tract2 C65-68 8 92.1 - 5.3 - 2.6
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 17 83.5 - 9.4 - 7.1
Thyroid gland C73 7 100.0 - - - -
Other endocrine glands C74-75 1 100.0 - - - -
Illdefined or unknown C76,C80 12 59.7 3.2 17.7 3.2 16.1
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 30 80.3 12.5 1.3 2.0 3.9
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 16 100.0 - - - -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 5 54.2 25.0 8.3 4.2 8.3
  Leukaemia C91-95 5 48.1 44.4 - 7.4 -
  Myelodysplastic syndromes D46 1 25.0 25.0 - - 50.0
  Myeloproliferaitive neoplasms D45,D47 1 66.7 - - - 33.3
Not included above
  Carcinoma in situ of the breast D05 13 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 32 100.0 - - - -
  Borderline tumour of the ovary D39 3 100.0 - - - -
  Basal cell carcinoma of the skin 124 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.